Long-term clinical outcomes of pancreatic cystic lesions in liver transplant patients
There is a low incidence of malignant transformation of PCL in OLT patients and no survival disadvantage at long-term follow up despite immunosuppression. PCL in OLT patients should be managed under similar guidelines as immunocompetent patients.
Authors
- Martin I. Montenovo (ORCID: https://orcid.org/0000-0001-8645-7797)
- Chandrasekhar Padmanabhan (ORCID: https://orcid.org/0000-0002-8715-1703)
- Salman Siddiqui (ORCID: https://orcid.org/0000-0003-3770-7870)
- Emma Bradley (ORCID: https://orcid.org/0009-0005-3250-6465)
- Anthony Gamboa (ORCID: https://orcid.org/0000-0003-0483-4654)
- Mark Radlinski
- Patrick Yachimski (ORCID: https://orcid.org/0000-0002-2529-4397)
- Marcus Tan (ORCID: https://orcid.org/0000-0003-0698-3936)
- Kamran Idrees (ORCID: https://orcid.org/0000-0003-0911-4461)
Institutions
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- HPB
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1016/j.hpb.2025.03.454
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Veterans Affairs